Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes

This study has been completed.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Juvenile Diabetes Research Foundation
Amylin Pharmaceuticals, LLC.
Merck Sharp & Dohme Corp.
Eli Lilly and Company
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Information provided by (Responsible Party):
Foundation for the National Institutes of Health Identifier:
First received: August 9, 2012
Last updated: July 14, 2014
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)